,2 Most (>90%) SM cases carry the KITD816 V mutation in the tyrosine kinase domain of the stem cell growth factor receptor gene (KIT), while other KIT mutations are present in a smaller percentage (≈1%–4%) of cases.3 This evidence concerns the gene KIT and systemic mastocytosis.